Konstantinos E. Farsalinos, M.D., needs no introduction amongst tobacco harm reduction advocates. An ex-smoker, cardiologist and research fellow at the Onassis Cardiac Surgery Center in Athens-Greece, at the Department of Pharmacy, University of Patras-Greece and at the National School of Public Health-Greece, he has been conducting laboratory and clinical research on e-cigarettes as a principal investigator since 2011.
As of late 2019, he has published over 80 studies and articles in international peer-reviewed scientific journals, about tobacco harm reduction, and has been recognized as one of the world’s most influential researchers of the past decade by Web of Science, receiving the Highly Cited Researcher 2019 recognition.
Here on the Vaping Post we have shared many of his studies, including studies looking for the presence of carbonyls in e-vapour, the cytotoxic effects of e-cigarette vapour on cultured cells and the immediate effects of e-cigarette use on cardiac function and coronary circulation.
Setting the record straight about vaping and COVID
“There has been global debate about the beneficial effects or otherwise of nicotine towards the chances of contracting Coronavirus and ensuing severity of outcomes once infected. Dr Farsalinos is one of the first in the world to analyze the mounting data and produce research suggesting that nicotine may have protective properties,” said the NNA on announcing the event.
“What exactly does the evidence tell us so far? Why are we seeing such wildly conflicting and confusing messages on the subject? What should we make of the nascent studies being undertaken in several countries to figure out the role of nicotine as a potential preventative force against Covid-19 and what should consumers make of it all?”
In the free online webinar Dr Farsalinos will go through current scientific studies on safer nicotine products, with the aim of discussing and clarifying any known associations between vaping/nicotine and the virus. There will be time allotted afterwards for attendees to ask him questions directly.
Places are limited and will be offered on a first come first served basis. Anyone wishing to register may do so here.
Full Event Details
Date: Thursday 18th June 2020
Time: 18:00 – 19:00 (BST)
Format & terms: Webinar – details for joining the online discussion will be sent to those confirming their participation.
Speaker: Konstantinos Farsalinos, University of Patras, Greece
Topic: ‘COVID-19 and the science of nicotine’
RSVP: Click HERE
Farsalinos Replicates Study on Toxicity Classification of E-Cig Flavouring Compounds
Let’s block ads! (Why?)